BioSpace News Archive

BioMidwest

nScrypt Bioprints PetVivo® Biomaterial for Orthopedic Implants

nScrypt is excited to announce the successful bioprinting of PetVivo® Holdings’ biomaterial, using nScrypt’s 3D Bio-Fabrication Tool.

October 20, 2020
·
3 min read
World Experts in Infectious Diseases & Critical Care Form Pluristem’s COVID-19 Steering Committee

Pluristem Therapeutics Inc., a leading regenerative medicine company developing a platform of novel biological products, named medical experts to form the Steering Committee for its clinical program relating to Acute Respiratory Distress Syndrome associated with COVID-19.

October 20, 2020
·
7 min read
Business

Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment

Samsung Biologics has entered into a partnership agreement with biotech Dinona, further expanding its CDO capabilities to provide a full scope of its development services from cell line development, process development, to non-clinical and clinical material manufacturing.

October 20, 2020
·
2 min read
Drug Development

IncellDx to Study Maraviroc, a CCR5 antagonist, in a COVID-19 Phase 2 Clinical Trial

IncellDx will collaborate on the SARS-CoV2 Clinical Trial NCT04435522 involving Pfizer’s FDA-approved CCR5 antagonist Maraviroc.

October 20, 2020
·
1 min read
BioMidwest

Focus Fund and MD Anderson Launch Investment Fund to Support Promising Investigational Cancer Therapies in Early-Stage Clinical Trials

Combination of over $50 million in committed capital along with access to cancer expertise and clinical facilities will help advance novel IND-ready candidates

October 20, 2020
·
7 min read
Business

Bruker Announces Date and Time of Third Quarter 2020 Earnings Release and Webcast

Bruker Corporation announced it will report third quarter 2020 financial results on Monday, November 2, 2020, after the market closes.

October 20, 2020
·
1 min read
Pharm Country

EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy

European Investment Bank and Immunic sign a financing agreement of up to €24.5 million to support the development of Immunic’s lead asset, IMU-838, in moderate COVID-19

October 20, 2020
·
9 min read
Pharm Country

Annovis Bio CEO Participates in Roundtable Discussion at the Financial Times’ Outstanding Directors Exchange and Panel Discussion at the Angel Venture Fair

Annovis Bio Inc. announced its Founder and Chief Executive Officer, Maria Maccecchini, Ph.D., will participate in the Financial Times’ Outstanding Director Exchange Roundtable: The Evolving Relationship Between Pharma and Biotech on Tuesday, October 20, 2020 at 11:40 a.m.

October 20, 2020
·
3 min read
Microbix Creates Further COVID-19 Quality Assessment ProductsQAPs™ to support accuracy of COVID-19 antigen-test workflows

Microbix Biosystems Inc., a life sciences innovator and exporter, announces its creation, external verification, initial sales, and first shipments of a new class of quality assessment products to help implement or ensure workflow accuracy of antigen-based tests for the virus causing COVID-19 disease.

October 20, 2020
·
6 min read
Policy

Revive Therapeutics Signs Supply Agreement With Havn Life Sciences for Psychedelic Compounds Expanding research and development of naturally-derived psilocybin for future FDA IND-enabling and clinical studies

Revive Therapeutics Ltd., a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has signed a supply agreement with Havn Life Sciences Inc.

October 20, 2020
·
6 min read